Skip to content
DataLookout
Menu

EPEGUTNCT07916948

Effects of Epetôme on Gastrointestinal Function, Inflammation and Wellbeing in Adults With IBS-like Symptoms (EPEGUT)

StatusNot Yet Recruiting
PhaseNot applicable
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Study First Submitted

Endpoints

Primary

Changes in gastrointestinal symptom severity
Timeframe: baseline, week 4 and week 12

Secondary (1)

Changes in digestive comfort

Arms and interventions

(Epetōme® Synbiotic Dual Cap®)Active comparator

A dietary supplement containing fructooligosaccharides (FOS), a prebiotic fibre, combined with probiotic microorganisms in capsule form.

Placebo comparatorPlacebo comparator

Matching placebo comparator

Dietary supplements: EPEGUT, Placebo

Sites

1 site in 1 country

  • University of Roehampton, School of Life and Health SciencesLondon, UK, United Kingdom